John L. Magnani - 11 Nov 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Reporting relationship: SVP of Research, CSO
Issuer ticker: GLYC
Reported as of: 11 Nov 2022
Net transaction value: +$52,703
SEC form: 4
Accepted by SEC: 14 Nov 2022, 15:11:48 UTC
Prior SEC filing: 10 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, attorney-in-fact

Key filing fact

John L. Magnani filed Form 4 for GLYCOMIMETICS INC (GLYC) on 14 Nov 2022.

Key facts

This page summarizes John L. Magnani's Form 4 filing for GLYCOMIMETICS INC (GLYC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Nov 2022, 15:11.

Change

Previous filing in this sequence was filed on 10 Mar 2022.
Current net transaction value: +$52,703.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLYC transaction

Common Stock

Purchase

Transaction value: $52,703
Shares: +45,045
Change %: +14%
Price: $1.17
Shares after: 366,078
Date: 11 Nov 2022
Ownership: Direct
Footnotes: F1

GLYC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,845
Date: 11 Nov 2022
Ownership: By GlycoTech Corporation
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.10 to $1.20 per share, with a weighted average purchase price of $1.17 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.